Related references
Note: Only part of the references are listed.Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
Hendrik Rathke et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
Andreas Hallqvist et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
A Single Dose of 225Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model
James M. Kelly et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617
Clemens Kratochwil et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
PSMA heterogeneity analysis in patients with metastatic castrate-resistant prostate cancer (mCRPC): Imaging versus CTCs.
Michael J. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617:Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Metastatic Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group
Andrea K. Miyahira et al.
PROSTATE (2018)
The poor outcome of patients with mCRPC whom were deemed ineligible for PSMA theranostics based on molecular imaging characteristics.
Sue Ping Thang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Radium and other alpha emitters in prostate cancer
Oliver Sartor et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2018)
Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab')2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival
Tom Back et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl) Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy
Ana P. Kiess et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
225Ac-PSMA-617 for PSMA-Targeted a-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Neeta Pandit-Taskar et al.
CLINICAL CANCER RESEARCH (2015)
Absorbed Doses and Risk Estimates of 211At-MX35 F(ab′)2 in Intraperitoneal Therapy of Ovarian Cancer Patients
Elin Cederkrantz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies
Malin Hagberg Thulin et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
Scott M. Knowles et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Simultaneous Targeting of Prostate Stem Cell Antigen and Prostate-Specific Membrane Antigen Improves the Killing of Prostate Cancer Cells Using a Novel Modular T Cell-Retargeting System
Claudia Arndt et al.
PROSTATE (2014)
Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
Johnnie J. Orozco et al.
BLOOD (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera Technique
Nicolas Chouin et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
Eric J. Lepin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The α-Camera: A Quantitative Digital Autoradiography Technique Using a Charge-Coupled Device for Ex Vivo High-Resolution Bioimaging of α-Particles
Tom Back et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Glomerular Filtration Rate After Alpha-Radioimmunotherapy with 211At-MX35-F(ab′)2: A Long-Term Study of Renal Function in Nude Mice
Tom Back et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
Hakan Andersson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of the Gastrin-Releasing Peptide Receptor, the Prostate Stem Cell Antigen and the Prostate-Specific Membrane Antigen in Lymph Node and Bone Metastases of Prostate Cancer
Hildo J. K. Ananias et al.
PROSTATE (2009)
Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen-Expressing Tumors
Jeffrey V. Leyton et al.
CLINICAL CANCER RESEARCH (2008)
Direct procedure for the production of 211At-labeled antibodies with an ε-lysyl-3-(trimethylstannyl)benzamide immunoconjugate
Sture Lindegren et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody
Tove Olafsen et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Dai Fukumura et al.
MICROVASCULAR RESEARCH (2007)
Dry-distillation of astatine-211 from irradiated bismuth targets:: a time-saving procedure with high recovery yields
S Lindegren et al.
APPLIED RADIATION AND ISOTOPES (2001)
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Z Gu et al.
ONCOGENE (2000)
Share Paper
